2020 – Page 3 – Hadean Ventures

What are you looking for?

NeuroVive makes a MSEK 20 directed share issue to leading Nordic life science investor Hadean Ventures

by @sassa on April 22, 2020

NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP) (”NeuroVive” or the ”Company”) has today decided upon a…
Continue Reading
Varsler massive coronakjøp, Finansavisen

by @sassa on April 16, 2020

Continue Reading
Neuro Event Labs Oy closes EUR 3.9m Series A investment round from Hadean Ventures, SHS Gesellschaft für Beteiligungsmanagement and Maki.vc

by @sassa on April 9, 2020

Continue Reading
Themis and Institut Pasteur Join Coronavirus Vaccine Hunt

by @sassa on March 20, 2020

The Austrian biotech Themis — specializing in vaccines for infectious and insect-borne diseases — has…
Continue Reading